ATORVASTATINE ARROW GENERIQUES 10 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930035320
  • CIP7 3003532
  • CIS 64408331

What the source publishes

Holder
ARROW GENERIQUES
Active ingredients
ATORVASTATINE, ATORVASTATINE CALCIQUE TRIHYDRATÉE
Form
comprimé pelliculé
Package
flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
liste I
Marketing status
Déclaration de commercialisation
Authorised on
2015-12-08
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930035320
{
  "cis": "64408331",
  "cip7": "3003532",
  "form": "comprimé pelliculé",
  "name": "ATORVASTATINE ARROW GENERIQUES 10 mg, comprimé pelliculé — flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)",
  "cip13": "3400930035320",
  "holder": "ARROW GENERIQUES",
  "routes": [
    "orale"
  ],
  "holders": [
    "ARROW GENERIQUES"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "4.20",
  "authorisedOn": "2015-12-08",
  "compositions": [
    {
      "name": "ATORVASTATINE",
      "nature": "FT",
      "strength": "10 mg",
      "linkageNumber": "1",
      "substanceCode": "19809",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "ATORVASTATINE CALCIQUE TRIHYDRATÉE",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "92464",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "3.18",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "ATORVASTATINE ARROW GENERIQUES 10 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2018-01-03",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "ATORVASTATINE",
    "ATORVASTATINE CALCIQUE TRIHYDRATÉE"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930035320"